Comprehensive overview of results in the study group. حسب Daniel Lilje (13104379)

الموضوعات:

Flow-chart of study group selection. حسب Daniel Lilje (13104379)

الموضوعات:

Beta diversity in the control and ampicillin-treated groups. حسب Seogwon Lee (11747633)

Fecal egg count reduction percentage (FECRP). حسب Sohail Afzal (10850709)

الموضوعات:

Mean total cholesterol levels over time in the roxadustat group (A) and ESAs group (B) according to the statins subgroup. حسب Jie Liu (15128)

الموضوعات:

Changes in the liver fibrosis-related markers in breast cancer patients with a FIB-4 index of >2.30 during letrozole treatment. حسب Kazuyoshi Ohkawa (836847)

الموضوعات:

Flowchart of patient selection in this study. حسب Kazuyoshi Ohkawa (836847)

الموضوعات:

Changes in the FIB-4 index in breast cancer patients with a FIB-4 index of ≥ 2.67 during letrozole and anastrozole treatment. حسب Kazuyoshi Ohkawa (836847)

الموضوعات:

Changes in the liver fibrosis-related markers in breast cancer patients with a FIB-4 index of >2.30 during anastrozole treatment. حسب Kazuyoshi Ohkawa (836847)

الموضوعات:

Clinical features and cancer treatment in patients with breast cancer receiving letrozole and anastrozole. حسب Kazuyoshi Ohkawa (836847)

الموضوعات:

S1 Data - حسب Kazuyoshi Ohkawa (836847)

الموضوعات:

Clinical course of patient no. حسب Kazuyoshi Ohkawa (836847)

الموضوعات:

AdMSC-EVs enhanced colony formation and migration of LECs and decreased proliferation. حسب Xiaoqin Li (1399105)

"…(C) The CFE of LECs from control group and EV-treated groups are presented as the mean ± SD. …"

Mean, SD, and Pearson correlations between SWB scales scores. حسب August Håkan Nilsson (12937056)

الموضوعات:

Histopathological changes in pre-treated group, treated group and normal diet group. حسب Yasmin Mohd Zainal Abidin Shukri (20558861)

الموضوعات:

Image 3_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg حسب Ling Kui (6108440)

"…</p>Results<p>Statistically significant reductions in skin lesion scores, S. aureus load, and AD-related immune mediators (i.e., IgE, TSLP, IL-33) were observed in the Staphyrase^® group relative to the model group. …"

Image 4_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg حسب Ling Kui (6108440)

"…</p>Results<p>Statistically significant reductions in skin lesion scores, S. aureus load, and AD-related immune mediators (i.e., IgE, TSLP, IL-33) were observed in the Staphyrase^® group relative to the model group. …"

Image 2_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg حسب Ling Kui (6108440)

"…</p>Results<p>Statistically significant reductions in skin lesion scores, S. aureus load, and AD-related immune mediators (i.e., IgE, TSLP, IL-33) were observed in the Staphyrase^® group relative to the model group. …"

Table 2_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.docx حسب Ling Kui (6108440)

"…</p>Results<p>Statistically significant reductions in skin lesion scores, S. aureus load, and AD-related immune mediators (i.e., IgE, TSLP, IL-33) were observed in the Staphyrase^® group relative to the model group. …"

Table 3_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.xlsx حسب Ling Kui (6108440)

"…</p>Results<p>Statistically significant reductions in skin lesion scores, S. aureus load, and AD-related immune mediators (i.e., IgE, TSLP, IL-33) were observed in the Staphyrase^® group relative to the model group. …"